RNTX NASDAQ
Rein Therapeutics Inc.
1W: +7.0%
1M: +3.3%
3M: -22.3%
YTD: -35.9%
1Y: -32.1%
$0.80
-0.05 (-6.03%)
Weekly Expected Move ±12.1%
$1
$1
$1
$1
$1
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
Supply Chain
📊 Key Metrics
TTM$0M
Revenue
+0.0% YoY
$-50M
Net Income
+6.6% YoY
$-19M
Free Cash Flow
-8.2% YoY
0.0%
Gross Margin
0.0%
Op. Margin
0.0%
Net Margin
💰 Income Flow
How revenue becomes profit💵 Cash Flow
⚠️ Cash Burn Where cash goes🏦 Balance Sheet
Assets = Liabilities + Equity📈 Financial Health
Profitability
ROE-753.6%
ROA-80.6%
ROIC53.9%
Valuation
P/E-0.4
P/B2.4
EV/EBITDA0.4
Leverage
Debt/Equity0.00
Current Ratio4.27
Interest Cov.0.0x
Quality Scores
Piotroski F3/9
Altman Z-8.94
Beneish M0.00